This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (21)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Martha E. Funkhouser, MD; Andy Ross, MD; Timothy G. Berger, MD
Craig Omohundro Department of Dermatology University of California San Francisco, CA 94143; Department of Dermatology, 4M70 San Francisco General Hospital 1001 Potrero Ave San Francisco, CA 94110

Arch Dermatol. 1993;129(7):911-913.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

A retrospective review of selected human immunodeficiency virus (HIV)-infected patients with scabies seen in our clinics between December 1990 and March 1992 revealed several clinical patterns with respect to morphologic findings and response to treatment. The Table lists representative cases with atypical clinical morphologic patterns or treatment responses. These patterns tended to correlate with helper T-cell count and the stage of HIV disease. Patients with CD4 counts above 1.5x10⁹/L had normal clinical morphologic patterns. Atypical morphologic patterns were restricted to patients with CD4 counts less than 1.5x10⁹/L. These included the following two different morphologic patterns:

1. Papular scabies is defined as a diffuse uniform eruption of 5- to 7-mm papules, each topped with a scabietic burrow. Each lesion is erythematous and inflamed, but a diffuse hypersensitivity rash is not a component. There may be associated pruritus, sometimes severe.
   
2. Norwegian scabies is defined as a generalized psoriasiform scaling and hyperkeratotic eruption. Thick, crusted plaques may be seen on the scalp, face, hands, buttocks, genitalia, and pressure-bearing areas. Pruritus may be slight to nonexistent.
   

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?